Cargando…
Impact of Bone Marrow Aspirate Tregs on the Response Rate of Younger Newly Diagnosed Acute Myeloid Leukemia Patients
Acute myeloid leukemia (AML) is widely considered a distinct clinical entity with a well-defined molecular and genetics-based prognosis. Particularly in a younger patient, the therapeutic approach depends largely on diagnostic risk stratification, which has an impact on the outcome after therapy. We...
Autores principales: | Delia, Mario, Carluccio, Paola, Mestice, Anna, Brunetti, Claudia, Albano, Francesco, Specchia, Giorgina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057333/ https://www.ncbi.nlm.nih.gov/pubmed/30069492 http://dx.doi.org/10.1155/2018/9325261 |
Ejemplares similares
-
After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia
por: Delia, Mario, et al.
Publicado: (2020) -
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia
por: Tota, Giuseppina, et al.
Publicado: (2014) -
Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia
por: Albano, Francesco, et al.
Publicado: (2013) -
Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances
por: Cumbo, Cosimo, et al.
Publicado: (2020) -
Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment
por: Piccolomo, Antonio, et al.
Publicado: (2020)